[1]
|
Kopin, L. and Lowenstein, C. (2017) Dyslipidemia. Annals of Internal Medicine, 167, ITC81-ITC96.
https://doi.org/10.7326/AITC201712050
|
[2]
|
Zhang, M., Deng, Q., Wang, L., et al. (2018) Prevalence of Dyslipidemia and Achievement of Low-Density Lipoprotein Cholesterol Targets in Chinese Adults: A Nationally Representative Survey of 163,641 Adults. International Journal of Cardiology, 260, 196-203. https://doi.org/10.1016/j.ijcard.2017.12.069
|
[3]
|
中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
|
[4]
|
赵静, 王育苗. 2016-2020年血脂异常管理研究进展与思考[J]. 中国实用内科杂志, 2021, 41(8): 729-734.
|
[5]
|
王碧晴, 赵俊男, 张颖, 等. 鬼针草的药理作用研究进展[J]. 中医药导报, 2019, 25(18): 100-103+107.
|
[6]
|
Zhang, R., Zhu, X., Bai, H., et al. (2019) Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Frontiers in Pharmacology, 10, 123. https://doi.org/10.3389/fphar.2019.00123
|
[7]
|
Ru, J., Li, P., Wang, J., et al. (2014) TCMSP: A Database of Sys-tems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, 13. https://doi.org/10.1186/1758-2946-6-13
|
[8]
|
Roth, G.A., Mensah, G.A. and Fuster, V. (2020) The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. Journal of the American College of Cardiology, 76, 2980-2981.
https://doi.org/10.1016/j.jacc.2020.11.021
|
[9]
|
Karantas, I.D., Okur, M.E., Okur, N.Ü., et al. (2021) Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives. Endocrine, Metabolic & Immune Dis-orders—Drug Targets, 21, 815-834.
https://doi.org/10.2174/1871530320666200810144004
|
[10]
|
Wang, Y., Yu, H. and He, J. (2020) Role of Dyslipidemia in Accelerating Inflammation, Autoimmunity, and Atherosclerosis in Systemic Lupus Erythematosus and Other Autoimmune Diseases. Discovery Medicine, 30, 49-56.
|
[11]
|
Gisterå, A. and Ketelhuth, D.F.J. (2018) Li-pid-Driven Immunometabolic Responses in Atherosclerosis. Current Opinion in Lipidology, 29, 375-380. https://doi.org/10.1097/MOL.0000000000000540
|
[12]
|
邹振武, 李德忠, 彭绪东, 等. 单味中药鬼针草颗粒治疗高脂血症的疗效及其对血清MMP-9、TIMP-1水平的影响[J]. 心血管康复医学杂志, 2019, 28(5): 661-665.
|
[13]
|
范琦琦, 张雪, 高梦迪, 等. 鬼针草降血脂有效部位的筛选及其指纹图谱的测定[J]. 当代化工, 2020, 49(4): 581-583+587.
|
[14]
|
Rezaei-Sadabady, R., Eidi, A., Zarghami, N., et al. (2016) Intracellular ROS Protection Efficiency and Free Radical-Scavenging Activity of Quercetin and Quercetin-Encapsulated Liposomes. Artificial Cells, Nano-medicine and Biotechnology, 44, 128-134. https://doi.org/10.3109/21691401.2014.926456
|
[15]
|
Xu, D., Hu, M.J., Wang, Y.Q., et al. (2019) Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules, 24, 1123. https://doi.org/10.3390/molecules24061123
|
[16]
|
Lee, S.M., Moon, J., Cho, Y., et al. (2013) Quercetin Up-Regulates Expressions of Peroxisome Proliferator-Activated Receptor γ, Liver X Receptor α, and ATP Binding Cassette Transporter A1 Genes and Increases Cholesterol Efflux in Human Macrophage Cell Line. Nutrition Research, 33, 136-143. https://doi.org/10.1016/j.nutres.2012.11.010
|
[17]
|
Alhajri, N., Khursheed, R., Ali, M.T., et al. (2021) Cardiovascular Health and the Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on the Gut Microbiota. Microorganisms, 9, 2013.
https://doi.org/10.3390/microorganisms9102013
|
[18]
|
Shi, T., Bian, X., Yao, Z., et al. (2020) Quercetin Improves Gut Dysbiosis in Antibiotic-Treated Mice. Food & Function, 11, 8003-8013. https://doi.org/10.1039/D0FO01439G
|
[19]
|
Francisco, V., Figueirinha, A., Costa, G., et al. (2016) The Flavone Luteolin Inhibits Liver X Receptor Activation. Journal of Natural Products, 79, 1423-1428. https://doi.org/10.1021/acs.jnatprod.6b00146
|
[20]
|
Boeing, T., de Souza, P., Speca, S., et al. (2020) Luteolin Pre-vents Irinotecan-Induced Intestinal Mucositis in Mice through Antioxidant and Anti-Inflammatory Properties. British Journal of Pharmacology, 177, 2393-2408.
https://doi.org/10.1111/bph.14987
|
[21]
|
Franza, L., Carusi, V., Nucera, E., et al. (2021) Luteolin, Inflammation and Cancer: Special Emphasis on Gut Microbiota. Biofactors, 47, 181-189. https://doi.org/10.1002/biof.1710
|
[22]
|
Ding, X., Zheng, L., Yang, B., et al. (2019) Luteolin Attenuates Athero-sclerosis via Modulating Signal Transducer and Activator of Transcription 3-Mediated Inflammatory Response. Drug Design, Development and Therapy, 13, 3899-3911.
https://doi.org/10.2147/DDDT.S207185
|
[23]
|
Kwon, E.Y., Kim, S.Y. and Choi, M.S. (2018) Luteolin-Enriched Ar-tichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity. Nutrients, 10, 979. https://doi.org/10.3390/nu10080979
|
[24]
|
Babaev, V.R., Ding, L., Zhang, Y., et al. (2019) Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Ath-erosclerosis in Ldl Receptor-Null Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 156-169. https://doi.org/10.1161/ATVBAHA.118.312206
|
[25]
|
Cortez-Cooper, M., Meaders, E., Stallings, J., et al. (2013) Soluble TNF and IL-6 Receptors: Indicators of Vascular Health in Women without Cardiovascular Disease. Vascular Medicine, 18, 282-289.
https://doi.org/10.1177/1358863X13508336
|
[26]
|
Pan, Q., Hui, D. and Hu, C. (2021) A Variant of IL1B Is Asso-ciated with the Risk and Blood Lipid Levels of Myocardial Infarction in Eastern Chinese Individuals. Immunological Investigations, 6, 1-8.
https://doi.org/10.1080/08820139.2021.1914081
|
[27]
|
Van Quickelberghe, E., De Sutter, D., van Loo, G., et al. (2018) A Protein-Protein Interaction Map of the TNF-Induced NF-κB Signal Transduction Pathway. Scientific Data, 5, Article ID: 180289. https://doi.org/10.1038/sdata.2018.289
|
[28]
|
Narayanan, K.B. and Park, H.H. (2015) Toll/Interleukin-1 Receptor (TIR) Domain-Mediated Cellular Signaling Pathways. Apoptosis, 20, 196-209. https://doi.org/10.1007/s10495-014-1073-1
|
[29]
|
MoghimpourBijani, F., Vallejo, J.G. and Rezaei, N. (2012) Toll-Like Receptor Signaling Pathways in Cardiovascular Diseases: Challenges and Opportunities. International Reviews of Immunology, 31, 379-395.
https://doi.org/10.3109/08830185.2012.706761
|
[30]
|
Kwon, E.Y. and Choi, M.S. (2018) Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Di-et-Induced Obese Mice. Nutrients, 10, 1415.
https://doi.org/10.3390/nu10101415
|
[31]
|
Zhang, Z., Yao, L., Yang, J., et al. (2018) PI3K/Akt and HIF-1 Signaling Pathway in Hypoxia-Ischemia (Review). Molecular Medicine Reports, 18, 3547-3554. https://doi.org/10.3892/mmr.2018.9375
|
[32]
|
Yu, Z.P., Yu, H.Q., Li, J., et al. (2020) Troxerutin Attenuates Oxy-gen-Glucose Deprivation and Reoxygenation-Induced Oxidative Stress and Inflammation by Enhancing the PI3K/AKT/HIF-1α Signaling Pathway in H9C2 Cardiomyocytes. Molecular Medicine Reports, 22, 1351-1361. https://doi.org/10.3892/mmr.2020.11207
|